MedCap AB (publ) (STO:MCAP)

Market Cap	8.40B -7.8%
Revenue (ttm)	2.37B +18.6%
Net Income	274.20M +39.3%
EPS	18.30 +39.0%
Shares Out	14.98M
PE Ratio	30.65
Forward PE	24.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,051
Open	548.50
Previous Close	551.50
Day's Range	545.50 - 561.00
52-Week Range	440.00 - 604.50
Beta	0.42
Analysts	n/a
Price Target	647.50 (+15.42%)
Earnings Date	Oct 23, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 663
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.73% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Analyst Summary

The average 12-month stock price target for MCAP is kr 647.50, which is an increase of 15.42% from the latest price.

Price Target

kr 647.50

(15.42% upside)

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error